| 000 | 01921cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030828.0 | ||
| 008 | 130427s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.24.Ph.D.2012.Sh.S | ||
| 100 | 0 | _aShereen Hassan Sadek Mourad | |
| 245 | 1 | 0 |
_aStudy the effect of chemoreduction in addition to focal therapy for group D retinoblastoma / _cShereen Hassan Sadek Mourad ; Supervised Carol L. Shields , Mohamed Mahmoud Elsayed , Mahmoud Ahmed Kamal |
| 246 | 1 | 5 | _aدراسة تأثير العلاج الكيماوى التحجيمى والعلاج الموضعى على المجموعة (د) من أورام الشبكية السرطانية عند الأطفال |
| 260 |
_aCairo : _bShereen Hassan Sadek Mourad , _c2012 |
||
| 300 |
_a138P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Ophthalmology | ||
| 520 | _aPurpose : To assess the effcacy of 6 cycles of chemoreduction and focal therapy for group D retinoblastoma . Design: Retrospective prospective nonrandomized non - comparative single- center interventional case series . Main outcome measures : Primary end point was ocular salvage using systemic chemotherapy intra-ophthalmic artery melphalan injection (IOAM) carboplatin subconjunctival injection with focal therapy including transpupillary diode thermotherapy (TTT) brachytherapy and cryotherapy | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aEgypt | |
| 653 | 4 | _aGroupD | |
| 653 | 4 | _aRetinoblastoma | |
| 700 | 0 |
_aCarol L. Shields , _eSupervisor |
|
| 700 | 0 |
_aMahmoud Ahmed Kamal , _eSupervisor |
|
| 700 | 0 |
_aMohamed Mahmoud Elsayed , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42791 _d42791 |
||